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1 Abstract 
Attention deficit disorder {ADD) is the most common type of mental disorder affecting children. 
It is estimated that around 6% of the total United States population is affected by this disorder. 
The exact causes have not been clearly identified, although studies show that there is a genetic 
component. Our aim is to build an individual-based stochastic model and use it to evaluate the effi-
ciency of the current treatment for ADD. We use a Markov chain approach to model the transition 
probabilities through different states in a population of children. The asymptotic distribution of 
the population of children across various states is computed as a function of the limiting probability 
of the transition probability matrix. The ratio of the proportion of children without the disorder 
to children with the disorder as a function of the probability of treatment efficiency is simulated 
and implications of variations on this ratio as a function of key parameters is described. The im-
portance of early and efficient treatment as well as diagnosis are highlighted through sensitivity 
analyses performed on the model. 
2 Introduction 
"Attention deficit hyperactivity disorder {ADHD) is a neuropsychiatry diagnosis for children pre-
senting with significant problems in the central nervous system (CNS) regulation of attention span, 
impulsiveness, and motor over-activity" [?]. It arises early in childhood, typically between 3 and 
7 years of age. "The disorder is relatively stable over time and persists through adolescence and 
into adulthood in more than half the cases" [?]. Throughout this paper we will be talking about 
ADD and ADHD as the same disorder, but for our purposes, we define them as an attention deficit 
disorder, but they are different severities of the same deficiency. 
This disorder reduces the level of concentration of glucose in the pre-frontal cortex of the brain 
making the person less attentive in any given situation. In other cases where that part of the brain 
is not functioning correctly, the side of the brain that deals with hyperactivity is always in use, 
making this individual constantly hyperactive one. There have been studies done to determine the 
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behavior of this disorder and the etiology of it. Although there is no exact understanding, it has 
been shown that it is partially hereditary. It is important to note at the ouset that ADD is not 
a unitary illness. "It is likely that a number of diferent pathways that include both genetics and 
environmental factors contribute to the expression of its symptoms" (?]. "Findings from a number 
of twin studies are consistent with a genetic hypothesis as are the results from a segregation analysis 
that suggested that ADHD might be the result of a single major gene with incomplete penetrance" 
(?]. "Notably, twin studies show that heritability of ADHD to be about 80%, indicating that the 
effect of genes is substantial" (?]. 
There exist several defining guidelines observed by the organizations, in charge of the clinical 
diagnosis of a child with ADD. "Because children typically underreport ADHD, and they frequently 
do not appear inattentive or hyperactive during a structured office visit, information obtained from 
parents and teachers is often required to make an accurate diagnosis" (?]. Symptoms criteria used 
to clinically diagnose an individual as having the disorder vary from country to country. These 
guidelines in the US are met around 50% of the cases. The US government spends over 3 billion 
dollars yearly in order to try to give the children who are diagnosed the correct treatment and 
education. For some reason a normal child can show all the symptoms necessary of being diagnosed 
as having the disorder, but just be a hyperactive child. 
There exists a manual, Diagnostic Statistical Manual(DSM-IV), which defines several symptoms 
that the therapist needs to observe in the child in order to give a correct diagnosis. These symptoms 
have to appear for more than 6 months and in two different living situations, such as school, house, 
etc. Usually once the child is diagnosed, s/he is analyzed and from there is determined which is 
the best treatment. Most of the time they are put on medication, which alters the functioning 
of the brain, or if the disorder appears to be less severe, then the child is given therapy. There 
has been a 45% decrease in visits where no drugs are prescribed, from 23.4% in 1994 to 12.8% in 
1996 (?]. There is a high percentage of individuals that do not meet the criterias to be clinically 
defined as having ADHD, but still are given medication and treated as individuals that have the 
disorder. In a study done by Bussing et a1.(2000), it was found that of the children which do not 
have the disorder 66% of them were still being treated with medication. Since this disorder is not 
considered a high risk disease, and since it is not well defined, medical insurance companies do not 
cover the expenses in most of all cases. Low-income families have a lower probability of ever getting 
the adequate treatment to control the disorder. ADHD does not affect individuals in any specific 
way. This is one of the main problems of diagnosing the disorder, there exists a wide array of the 
severity of the disorder and is difficult to understand the point where a hyperactive child is not 
just hyperactive, but has a brain response deficiency. On a recent report(?] researchers defined the 
psychopharmacology of ADD, and presented a series of results that are not as reassuring as they 
expect them to be. They portrayed ADD as one of the most effectively treated child disorders. 
Treatment studies and clinical experiences suggested that there exists a short term effectiveness 
of the pharmacological strategies, along with an increased in the percentage of children being 
prescribed medication, a recent study shows that there exists an undertreatemnt of the disorder, 
of 5% of children which met criteria for ADHD, only 13.6% of those children were being treated 
correctly. This undertreatment of the disorder and misdiagnosis of the symptoms lead us to try to 
give an explanation of the problems that these individuals are facing. 
Based on a series of complications above mentioned, we will use a stochastic model to get 
more insight into the efficiency of the treatment. One of our main goals is to set up a base for 
a regression analysis model in order to estimate the ratio of a child without disorder to an child 
with the disorder, given the efficiency of the treatment. The outputs of our simulations are used 
to create a regression equation that gives us a good estimate of the probability of an child with the 
disorder to one without the disorder. 
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3 Methodology 
We employ a finite state Markov chain to model the dynamics between different classes of individuals 
for the population of interest. The limiting probability of this Markov chain is used to compute 
the expected time that an individual spends in a class. The expected time spent in a class is then 
utilized to estimate the distribution of the population among all classes in the long run. It is of our 
interest to simulate the ratio of children without ADD to children with the disorder as a function 
of the probability of inefficient treatment. 
In the following, n-vectors are considered as columns vectors, thus if 1r E Rn, we then write 
1rT = (1ro, 1r1. ... , 1rn-d· Let Xt denote a Markov chain with finite state space 0, 
where 0 = {0, 1, 2, ... , n}. Let us define 
where 
P[j = P{Xs+m = j/Xs = i} 
this is, Plj denotes the probability of passing from state i to state j after m-steps. It follows from 
Chapman-Kolmogorov equations that, for a fixed j we have, 
n 
1rj = L 1rkPkj 
k=O 
(1) 
Let P denote the n-by-n matrix of one-step transition probabilities, whose ij-entry is given by Pij· 
In view of (1), we can easily see that the vector 1r satisfies, 
Also, letting 1 ERn, with lT = (1, 1, ... , 1), recall that, 
1T 7r = 1 
(2) 
{3) 
The vector 1r is known as the limiting probability. Next, let J = 11 T, in other words, all entries of 
J are equal to 1. Let I denote the n-by-n identtity matrix, and Q = 17rr, this is to say, every row 
of Q is equal to 1rT. Thus, it follows that, 
Q+QJ=QP+QJ 
hence, in view of (3) and definition of J, we obtain, 
J=Q(P+J- I) 
therefore, provided that (P + J- I) is nonsigular, an expression for 1r is given by, 
(4) 
Observe that by using Sherman-Morrison- Woodbury formula an expression for the inverse of P + 
J- I can be found. In fact, the existence of such an inverse relies on the nonsigularity of P-I, 
please see [?) for details. We arc employing a closed-loop stochastic model in accordance with the 
approach proposed by Hermindez-Suarez in [?). Therefore, the dead-state and the newborn-state 
are both represented by fl. E n. An individual's life span is then modeled by the trajectory of 
transitions between different states until it returns to fl.. 
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Henceforth, fix i, i E {0, 1,2, ... ,n -1}. 
Let Ei be the expected time that an individual spends at a class i, which is given by 
E .- 1Ti.!. 
'- 1Tn Oi 
(5) 
where Oi denotes the rate at which an individual leaves class i. 
Now, let 1r; denote the stationary probability that an individual is at the i-th class, which is 
given by, 
* Ei 1T· = --...--
' ("~-1 E·) L....-;=0 J 
(6) 
The ratio of children without ADD to children with the disorder, is modeled by an expression 
as the following, 
7r~ 
r=.....!... 
7r'!' 
J 
where i =I= j. In order to implement numerical simulations we let r be a function of c, the probability 
of inefficient treatment, this is to say, 
r = r(c) 
Our approach is the first effort for having a way to estimate the ratio of people without the disorder 
to people with it once the probability of treatment efficiency is provided. A regression analysis can 
be based on our simulations to obtain such an estimate. 
4 Models Assumptions and Parameters 
Parameters for the three models investigated in this study are presented in Table 1. A number of 
assumptions are made in this study. We consider a population of children with age varying from 
3-18 years. We further assume that state 1:1 closes the open-loop system, meaning that the input 
(in-born children) comes from it and the output (adult-people) goes to it. Thus, 1:1 is a reflecting 
state, in other words, the transition between 1:1 and another state in the system has probabilty one. 
In the following, we present models where the transition is given from 1:1 to Xo (this state will be 
defined in the following paragraphs). 
4.1 4-State Model 
In this model we have the following states: children not expressing the disorder, children with 
ADD, children receiving treatment, and the adult state. By children who are not expressing the 
disorder, we mean children who do not have ADD, as well as people who had it and are recovered 
through treatment. Notice that the efficient treatment for ADD does not fix the genetic disorder, 
it only relaxes the limitations of the affected individual to facilitate his/her adaptation in society. 
Let Xo denote the state of functional children. Let X1 be the state of children with ADD. Let 
T denote the treatment state, and 1:1 be the adult state. 
Recall, that n denotes the finite-state space. Thus, 
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Parameter Definition 
J.L rate at which a child becomes an adult 
(7 rate of acquiring ADD 
</> rate of finishing treatment 
'Y rate of diagnosis 
d probability of misdiagnosis 
c probability of inefficient treatment 
B rate of getting ADD by environmental factors 
a rate of getting ADD by misdiagnosis 
r probability of treatment by medication 
1-r probability of treatment by therapy 
t probability of inefficient treatment by medication 
q probability of inefficient treatment by therapy 
Table 1: List of Parameters 
Next, the matrix of one-step transition probabilities, namely, P, is given by 
( {!~c) u 1d " ) J.L+-yd+u J.L+-yd+a J.L+rd+a 0 -y(l-d} J.L P= -y(l-d)+J.L 1(1-f+" (7) c 0 
0 0 
Now, recall that 1rT = (7ro, 1r1, 1r2, 1r3). We have found the following expression for 1r by applying 
* 7ro 
* 7rl 
* 1!"2 -
(( -1 +c)( -1 + d)'y + JL)</> 
-d2[2 + {(7 + ( 1 - C[ + J.L + (7 )</> + d1( 1 + J.L - a - </> + 2c</>) 
(cd'Y +a )I 
-d21 2 + {(7 + ( 1 - C/ + J.L + (7 )</> + d!( 1 + J.L - (7 - </> + 2c¢) 
'Y( -(7 + d( ( -1 + d)'Y - J.L + (7)) 
-d21 2 + {(7 + ( 1 - C/ + J.L + (7 )</> + d[( 1 + J.L - (7 - ¢ + 2c¢) 
It follows from figure 1 that children leave the state Xo because either they are misdiagnosed, 
acquire ADD, or become adult. Recall that 1 denotes the rate of receiving treatment and d is 
the probability of misdiagnosis. Hence the rate at which children in Xo receive treatment as a 
consequence of misdiagnosis is given by {d. Also, individuals in Xo acquire ADD at a rate (7, and 
become adults at a rate p,. As pointed out before, individuals are arriving to the system through 
Xo. This state receives children from state Tat a rate </>{1- c), where c denotes the probability of 
treatment inefficiency, and </> denotes the rate at which individuals leave treatment class to Xo. 
Concerning the state X1. children either leave for treatment, or become aldults. Children leave 
for treatment at a rate 1(1 -d), or become adults at a rate J.L· Observe that there is no transition 
from Xt to Xo, since there docs not exist a natural recovery from ADD. Since </>denotes the rate 
of leaving treatment and c denotes the probability of treatment inefficiency, children from state T 
arrive into state Xt at a rate ¢c. 
Now, let us assume that the system input goes from A to X1. Hence, Pis given by, 
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f'(l-c) 
x. (J 
f'C 
}J }J 
Figure 1: 4-State simulation, input into Xo 
p ~ (¢(!~c) (1' ld " ) ~t+-rd+u ~t+-rd+u ~t+;d+u 0 n(l-!fl I!: ;l-d)+J.L ,(IT+" ¢c 0 
1 0 
{8) 
We can see in figure 2 the diagram of the 4-state model, for which the rates are the same as in 
the previous case. 
91(1-c) 
}J }J 
Figure 2: 4-State simulation, input into X1 
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Using equation (4], the stationary probability 1r is given by, 
* 11'o = 
* 1rl = 
{-1 + c){-1 + d)'Y</> 
-( -1 + d)-y(d-y + J.L + u) + ((1- d + c( -d))'Y + J.L + u)</> 
( cd-y + J.L + (1 )</> 
-( -1 + d)'Y(d-y + J.L + u) + ((1- d + c(-1 + 2d))'Y + J.L + u)</> 
( -1 + d)'Y( d-y + J.L + (1) 
-( -1 + d)'Y(d-y + J.L + u) + ((1- d + c( -1 + 2d))'Y + J.L + u)</> 
4.2 3-State Model 
The states for this model are: children eithout ADD, children with ADD, and adult state. 
Let Xo denote the state of children without ADD. Let X1 be the state of children with ADD. 
We are letting </> to be large enough such that the treatment is instantenous. Recall the the average 
time spent at state T is given by ~. 
In this model, the finite-state space 0, is defined as follows, 
Let P be given by, 
(9) 
We have 
11'o </> = 
u+-yd+</> 
1ri 
u+-yd 
= 
u+rd+</> 
cr 
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4.3 6-State Model 
The following states are considered in this model; children without ADD, children with ADD, 
treatment with medication, treatment with therapy, children with ADD who become functional 
through treatment, and the adult state. 
Let Xo denote children without ADD, X1 denote children with ADD, TM denote treatment 
through medicaton, Tr denote treatment through psychiatric therapy, X2 functional children 
through treatment, and/:). denote the adult state. 
4.4 
Therefore, n is given by, 
n = {Xo,X~,Tm,Tt,X2,~} 
The one-step transition probability matrix P is as follows, 
0 9+a{l-~ 0 0 0 JL+B+a(l-d) 
0 0 ..:1!:__ -y{l-r) 0 
'Y+JL -r+JL 
P= 0 t 0 0 {1- t) 
0 q 0 0 {1- q) 
0 0 0 0 0 
1 0 0 0 0 
6-State Model 
X 
X 
~ JL+B+a:( 1-d) 
_1!:_ 
-r+JL 
0 
{10) 
1 
0 
X 
Figure 4: This is the model designed for the possible treatments by entering an individual through 
Xo. 
In this model we identify each individual more specifically, along with the treatment the indi-
vidual is given. We have 5 groups of individuals in accordance to the description of the individual 
at a certain time. The individual in Xo is a child who is not born with the disorder and do not 
carry the disorder in their gene description. This child is still capable of getting the disorder; either 
by environmental factors, or by being wrongfully treated with medication and therapy that makes 
them behave as a child with the disorder, even though the child docs not have it. The individual in 
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X 1 is a child that has the disorder, and are expressing the symptoms associated with it. This child 
might go into either type of treatment available, or stay in that state since he did not seek any 
treatment. The first treatment available for the child that demonstrates the disorder is TM. This 
treatment is defined as a child that receives any type of treatment along with being prescribed a 
drug medication to control their behavior. In this state once the child finishes the treatments/he 
might be capable of functioning well in a social environment or if the medication does not work, 
then s/he goes back to X 1. As seen on the model, the only way to get out of treatment is by being 
correctly treated or if the treatment is inefficient. We are assuming that the child does not go into 
adulthood under any of the compartments defined as treatments. The other type of treatment, Tr, 
is the treatment in which the child gets only therapy or some type of special education that does 
not involve any type of medication. This child has the probability of returning to X 1, meaning that 
the treatment was inefficient, or go into X2 by finishing the treatment positively. The next state, 
X2, is the child that has undergone treatment and is defined as clinically being stable to handle 
normal social situations. We also define this child as one who has the possibility of still taking 
medication but it is on a constant dose just to the keep the disorder under control. This model 
observes the efficiency of the treatment once the child has the disorder, by defining them into a 
new state. The treatments are divided in two categories to observe which of the treatments is the 
most effective. 
Based on the model chosen and the probability of going from one group to another once we 
introduce an individual as one that is not believed to have the disorder genetically, by observing 
the basic probability flow of the system we can hypothesize that if we introduce a child into Xo, 
the probability of finding him is higher in X 0 , than in any other of the states, so the probability 
of finding an individual in any of the treatment states should be the lowest. If we introduce an 
individual in the X1 state, the probability of him going to Xo is 0, since there is no way of entering 
that state if you get out of there. Based on the values assigned to each variable once you are in 
X1, the probability of going to any other group is much higher than if you had previously started 
in Xo. So in conclusion we hypothesize that even though there should be a high probability of 
finding the child in X1, we say that there will be a higher probability of finding a child in X2, in 
comparison to the previous entry of the model. 
These are the equations for the treatment specified model, were the child entered does not have 
the disorder genetically, and s/he still has probability of moving to any of the other groups. 
7To -
• 7Tl 
• 7T2 -
• 7T3 -
• 7T4 = 
J.t((1 + q( -1 + r)- rt)'y + J.t) 
(1 + q( -1 + r)- rt)'y(O + J.t) + J.t(30 + J.t)- ( -1 + d)a((1 + q( -1 + r)- rt)'y + 3~-t) 
(( -1 + d)a- O)J.t 
-{1 + q( -1 + r)- rt)'y(O + J.t)- J.L(30 + ;;.) + ( -1 + d)a((l + q( -1 + r)- rt)!' + 3J.L) 
((1 + q( -1 + r}- rt)'y + (( -1 + d)a- 0) 
-(1 + q( -1 + r)- rt)'y(O + J.t) + J.t(30 + J.t)- ( -1 + d}a((1 + q( -1 + r)- rt)'y + 3~-t) 
(( -1 + d)a- O)J.t 
-(1 + q( -1 + r)- rt)'y(O + J.t) + J.t(30 + J.t)- ( -1 + d)a((l + q( -1 + r)- rt)'y + 3~-t) 
((-1+d)a-O))J.t 
-(1 + q( -1 + r)- rt)'y(O + J.t) + J.t(30 + J.t)- ( -1 + d)a((1 + q( -1 + r)- rt)'y + 3~-t) 
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X 
X 
Figure 5: This is the model designed for the possible treatments by entering an individual through 
Xt. 
These are the equations for the case where the child enters having the disorder genetically: 
7l"o = o 
ni J.t = (1 + q( -1 + r)- rt)'y + 31-£ 
n2 (1+q(-1+r)-rth (1 + q(-1 + r)- rt)'y + 31-£ 
n* J.t 3 - (1 + q( -1 + r)- rt)'y + 3J.t 
n4 J.t - (1 + q(-1 + r)- rt)'y + 3J.£ 
5 Analysis and Numerical Results 
Rates 
In order to construct the model we had to relied on previous studies, and collect all information 
necessary to understand the definitions of the parameters and the meaning of the values assigned 
to each of them. We will justify as much as possible why the parameters were given the values 
specified. 
Parameter J.t, gives the rate at which a child becomes an adult. Since we want to model this 
from the beginning stages of the disorder, we start at age 3 and go until age 18, J.t = ls. 
a is the rate at which a child gets the disorder genetically. It is known that 1 out of 30 children 
have the disorder on average, and around 70% of the cases are due to heredity, so we estimate 
1 every 12 years a child might get the disorder genetically, a = 112 • 'Y is the rate at which a 
child gets diagnosed with the disorder per year. We assume a range of possible outcomes, and we 
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chose it to be a value between ~ and h. a child gets diagnosed with the disorder every year, since 
there exist different probabilities of diagnosis. 4> is the rate at which children leave the treatment. 
This definition is rather broad, since by finishing treatment we mean, that they have been given a 
specified dose of medication that would control their behavior in such a way that they can function 
at a normal level in society. Although not all individuals need to have this dosage throughout their 
lifetime, we also need to define this rate. From previous studies done, researchers have said that 
around 50 - 65% of children take their disorder into adulthood, and that around 70% of the time 
the treatment is efficient, so this rate depends on the rate defined to/, and this would be 60% of 
the value of 'Y = 1~ to 2~ . 
() is the rate at which a child could get the disorder by other components other than genetically, 
these were defined in our introduction to be environmental factors, such as lead poisoning, home 
behavior etc. It has been found that around 15% of the individuals can acquire the disorder due to 
this type of exposure for which we approximate this rate as being A. Every year a child is prone 
to be exposed to these affecting factors. 
Probabilities 
On the 2-box model d is the probability of being diagnosed with the disorder. This value is different 
for the other boxes and ranges from 50-75% to study the optimized value for the model. 
On the 3-box model we have defined d to be the probability of being incorrectly diagnosed with 
the disorder. On average around 5-15% of children might be misdiagnosed with the disorder. In 
this case we would like to study the cases when the misdiagnosis is from 0 to 100%. 
On the 5-box model we have assigned d as the probability of getting add by genetic factors. 
c - is the probability of an inefficient treatment. Observational studies have found a 30% 
probability of treatment failure. In simulations performed c ranges from 0 to 100%. 
r- defined as the probability of treatment by medication. And is sent to treatment, then this 
person has certain probability of getting either of the two types of treatments, being treated with 
medication, and being treated with therapy, (1-r). We want to send more individuals tor, since 
from data collected, a high proportion of individuals treated, are treated by medication,around 
80% of children treated are with medication. 
t - defined as the probability of inefficient treatment if s/he is prescribed medication. Research 
studies have found that around 30% of the time medication is inefficient. 
q - defined as the probability of inefficient treatment by therapy. The research done did not give 
us any exact percentage of individuals that finish this type of treatment inefficiently but we chose 
it to be aroun 45%, since there has been a decrease in using only this type of prescription. Since 
we want to vary this value, we chose the fixed value whenever we wanted to vary the probability 
value oft. 
5.1 4-State Model 
Let i E {0, 1, 2}. 
Our simulations are graphs of 1r; = 1r;(c), fixing d with values {0.01,0.05,0.1,0.2,0.35}. We 
,... 
also graph ;¥- as a function of c. 
1 
The simulations were performed for both cases: system input in Xo as well as system input in 
x •. 
It is observed that, ~' i.e., that the ratio of children without ADD to children with it , decays 
""1 
as the treatment becomes more inefficient. 
It is also observed that for fairly efficient treatment, more children are conglomerated in the 
state Xo than in X 1, this is, for values of c near to zero. Whereas, for treatment nearly inefficient, 
11 
more individuals seem to be merge into Xt than in Xo. Despite this behaviour the ratio~ decays 
'~~"t 
smoothly to zero as c tends to one. 
·-:~~ ~: 
1.0 
1 
O.I!So~-o::':.1--:o.2-=---:o:'7.o-~o.•=---:o~.o -::':o.e:----=o"=-.7 -o::':_,--:o.=-o ~1 
c 
~~~-~'l 
0 ~ ~ ~ ~ ~ ~ u ~ - 1 
c 
Figure 6: ~as a function of inefficiency c 
In Figure ?? we see how the ratio ~ decays faster for higher values of d, this is, for high '~~"t 
probability of misdiagnosis. Using the data generated for the simulations shown in Figure??, we 
performed a regression analysis. Through this analysis, we observed that for nearly-zero values 
of probability of misdiagnosis there exists a linear relationship between ~ and c, the probability 
11"1 
of treatment inefficiency. Whereas that for values of d close to 0.35, there exists a quadratic 
relationship between ~ and c. 
11"1 
0:~ : : ; __ -i---- ; -_; --=--- : -- t] 
0 0 f 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.8 1 
0 :1 ; : ~- -i -; -- _:_ --=--- _:_ • 1 
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Figure 7: Stationary distributions with input through Xo and Xt. 
In Figure ?? we see how the ratio ~ decays faster for higher values of d, this is, for high 
11"1 
probability of misdiagnosis. Using the data generated for the simulations shown in Figure??, we 
performed a regression analysis. Through this analysis, we observed that for nearly-zero values 
of probability of misdiagnosis there exists a linear relationship between ~ and c, the probability 
1 
of treatment inefficiency. Whereas that for values of d close to 0.35, there exists a quadratic 
relationship between ~ and c. 
1 
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5.2 3-State Model 
Several simulations were made of the model varying the probability of misdiagnosis to see what is 
the stationary probabilty that an individual is at a certain class as a function of phi, the rate of 
leaving the treatment. 
Figure ?? shows the result of a simulation when the misdiagnosis probabilty is .1. For small 
values of phi, which means that the reovery time is very long, it is shown that there are more people 
with ADD than in the functional class. As phi increases, individuals are being cured at a faster 
rate, so the probabilty of the individual to be in the functional class increases. 
Another simulation is made increasing the probabilty of misdiagnosis to .35. 
It is seen in Figure ?? how and increase in the rate of misdiagnosis causes the point at which 
both groups are equal to be at a higher value of phi. This is because more people are being 
misdiagnosed and they go to the ADD class so it takes a faster treatment for the people to leave 
the class. It is also evident that for high values of phi, the stationary probability of being in the 
ADD class is higher than the case when the probability of misdiagnosis is lower. 
5.3 6-State Model 
In the simulations we hoped to observed what happened when the probability of entering into 
treatment and the probability of making one of the treatments is increased. 
In our graphs we will plot on 1ri vs. r and q, since the graphs with varying t are the same except 
it decreases in the other extreme value of r. A few of those graphs are plotted in the appendix. 
From the different 1ri we will look at the graphs that will give us the information we are looking 
for. 
As we can see in ?? as we increaser and q, the change in probability is not that significant to 
the complete change of extremes, since the probability of exiting this group does not involve r and 
t. 
On ?? , the plot gives us very important information, as we decrease the value of r, this means 
that we will be sending at a higher rate the child to Tr, and by increasing q, we are sending the 
child back to X 1, this meaning that the treatment with therapy is ineffective. 
As seen in this graph as we decrease rand increase q, we see that the value of 1r2, decrease since 
everybody that has been treated returns to demonstrating the symptoms of ADD, and so forth 
s/he will not be able to be treated efficiently. The graphs of 1r3,1r4 are both increase as r goes to 0 
and q goes to 1. The interesting output is when a child that is known that has the disorder due to 
genetic hereditability is introduced in the model through X1, the movement to TM and Tr shows 
us how we would expect the probability to change as we change the values of q. 
6 Regression Analisys 
Based on the simulations we built for our models, we are able to plot a regression line on Minitab, 
and this gives us a regression equation for determining the ratio of being in 1ro to 1r1. The importance 
of this equation is that we found that as we get a complicated model we would need a higher degree 
polynomial to fit the regression in order to give a better estimate. For our model of having the 
disorder at 35% inefficiency we had to fit a quadratic curve in order to get a good estimate of our 
ratio. Once we have determined our correct parameter values for each flow in and out of a class, 
we can make a regression equation, that would let us estimate the ratio of being in any given class, 
by just knowing the efficiency of the treatment given to the patient. 
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7 Conluding Remarks 
Using an irreducible ergodic Markov chain, we have computed the stationary proportion of children 
in each state of our model. We were able to optimize the ratio of proportion of children without 
ADD to children with it, by adjusting the treatment inefficiency and improving the diagnostic 
tools. A regression analysis can be used to estimate the ratio of proportion of children without 
ADD to children with it, given the treatment inefficiency. Within a confidence interval the ratio of 
proportion mentioned previously, behaves as a quadratic function of the probability of treatment 
inefficiency. We conclude that the ratio of proportion of children without ADD to children with it, 
can be used as a measure of the population treatment effectiveness. This is, by studying how this 
ratio of proportion varies as a function of the treatment inefficiency and misdiagnosis, the effect of 
the treatment at a population level can be measured. 
8 Future Work 
We consider appropriate to propose and analyze a regression model of the guidelines used to diag-
nose ADD. An age-structured like model can be proposed to study the effectiveness of treatment 
for ADD. The stochastic approach applied in the models studied in this project can be extended to 
model more realistic instances. Moreover, this methodology may be applied to build up models in 
order to study other disorders. We recommend to complement the results obtained with a precise 
study employing ADD observed data. We also propose to create a cost sensitivity analysis of our 
model, in order to determine which is better, to vary, treatment efficacy or diagnosis in order to 
improve recovery. 
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Figure 8: 1r as a function of (c,d) with input through Xo and X1 . 
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Figure 11: This is the probability plot of 1ro when we vary rand q. 
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Figure 12: This is the probability plot of 1r1 and 1r2 when we vary r and q, and the child enters 
through Xo. 
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Figure 13: This IS the probability plot of 1r3 and 1T4 when we vary r and q and the child enters 
through xl. 
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Figure 14: This is the regression lines done to predict the ratio of 1ro to 1r1 based on the treatment 
efficiency. 
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